Shelley M. Herbrich

Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer

Reva Basho, Michael Z. Gilcrease, Rashmi K. Murthy et al. · JAMA Oncology · 2016 · 186 citations

Statistical Inference from Multiple iTRAQ Experiments without Using Common Reference Standards

Shelley M. Herbrich, Robert N. Cole, Keith P. West et al. · Journal of Proteome Research · 2012 · 140 citations

Isobaric Tags, Engineering, Common Reference Standards +21

Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis

Tamara Ratovitski, Ekaterine Chighladze, Nicolas Arbez et al. · Cell Cycle · 2012 · 135 citations · Full text

Huntingtin Protein Interactions, Mitochondrial Dysfunction, Molecular Biology +18

A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer

Sherry Y. Wu, Rajesha Rupaimoole, Fangrong Shen et al. · Nature Communications · 2016 · 119 citations · Full text

Cancer Biology, Tumor Biology, Mir-192-egr1-hoxb9 Regulatory Network +16

Molecular Biomarkers of Residual Disease after Surgical Debulking of High-Grade Serous Ovarian Cancer

Susan L. Tucker, Kshipra M. Gharpure, Shelley M. Herbrich et al. · Clinical Cancer Research · 2014 · 92 citations · Full text